Market Cap 498.59M
Revenue (ttm) 1.88B
Net Income (ttm) -534.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28.49%
Debt to Equity Ratio 2.52
Volume 3,477,300
Avg Vol 3,264,242
Day's Range N/A - N/A
Shares Out 113.06M
Stochastic %K 87%
Beta 0.80
Analysts Strong Sell
Price Target $5.62

Company Profile

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggreg...

Industry: Health Information Services
Sector: Healthcare
Phone: 571 389 6000
Address:
1812 N. Moore Street, Suite 1705, Arlington, United States
BPler
BPler Aug. 18 at 7:47 PM
$EVH https://www.marketbeat.com/instant-alerts/evolent-health-nyseevh-price-target-raised-to-600-2026-08-18/
0 · Reply
PatBtmn
PatBtmn Aug. 18 at 7:28 PM
0 · Reply
BRITLS
BRITLS Aug. 18 at 7:20 PM
$EVH hmm
0 · Reply
StellaLunaSun
StellaLunaSun Aug. 18 at 4:20 PM
$EVH @BPler I just wanted to do something nice for you – maybe it’ll help you, and you’ll be pleased with it – so I’ve picked this out for you. Best wishes https://www.marketbeat.com/instant-alerts/evolent-health-nyseevh-price-target-raised-to-600-2026-08-18/
0 · Reply
BPler
BPler Aug. 18 at 1:54 PM
$EVH Averaging down, at this point there is only upside in my
0 · Reply
PatBtmn
PatBtmn Aug. 17 at 6:24 PM
$EVH fuck it
0 · Reply
TOMKiLA
TOMKiLA Aug. 15 at 12:43 AM
$EVH I can wait here for big changes, I’m very ready to read about good news. $650M new agreements in the first half 2026, this is very good news. I mean, this company is offering different serivices and the big names are coming quickly. I’m very sad about the EBITDA forecasts for next year because is like 4.5% of gross profits (the company was talking about 10%). Something is cooking probably, this company is very interesting
0 · Reply
StellaLunaSun
StellaLunaSun Aug. 14 at 8:11 AM
$EVH https://seekingalpha.com/news/4632078-michael-burry-adds-to-molina-healthcare-position-cites-long-term-outlook-and-political-catalyst
0 · Reply
Zephix
Zephix Aug. 13 at 9:27 PM
0 · Reply
Zephix
Zephix Aug. 13 at 8:44 PM
$EVH Today0
0 · Reply
Latest News on EVH
Citi upgrades Evolent Health to Buy after 30% selloff

2026-08-10T20:15:27.000Z - 8 days ago

Citi upgrades Evolent Health to Buy after 30% selloff


Evolent Health upgraded to Buy from Neutral at Citi

2026-08-10T20:11:18.000Z - 8 days ago

Evolent Health upgraded to Buy from Neutral at Citi


Evolent Health Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 13 days ago

Evolent Health Earnings Call Transcript: Q2 2026


Evolent Health Earnings release: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 13 days ago

Evolent Health Earnings release: Q2 2026


Evolent Health Slides: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 13 days ago

Evolent Health Slides: Q2 2026


Evolent Health Quarterly report: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 13 days ago

Evolent Health Quarterly report: Q2 2026


Evolent Health reports Q2 adjusted EPS 2c, consensus (2c)

2026-08-06T11:57:25.000Z - 13 days ago

Evolent Health reports Q2 adjusted EPS 2c, consensus (2c)


Evolent Announces Second Quarter 2026 Results

Aug 6, 2026, 7:00 AM EDT - 13 days ago

Evolent Announces Second Quarter 2026 Results


Evolent Health price target lowered to $5 from $8 at TD Cowen

2026-07-28T12:36:50.000Z - 21 days ago

Evolent Health price target lowered to $5 from $8 at TD Cowen


Evolent Health downgraded to Sell from Buy at Citi

2026-07-23T09:05:09.000Z - 27 days ago

Evolent Health downgraded to Sell from Buy at Citi


Evolent Health price target raised to $7 from $6 at Canaccord

2026-07-21T10:56:25.000Z - 4 weeks ago

Evolent Health price target raised to $7 from $6 at Canaccord


Evolent Health downgraded to Hold from Buy at Truist

2026-06-30T09:25:31.000Z - 7 weeks ago

Evolent Health downgraded to Hold from Buy at Truist


Evolent Health price target raised to $5.50 from $4 at Citi

2026-05-15T10:52:20.000Z - 3 months ago

Evolent Health price target raised to $5.50 from $4 at Citi


Evolent Health price target raised to $6 from $5 at Canaccord

2026-05-12T11:20:59.000Z - 3 months ago

Evolent Health price target raised to $6 from $5 at Canaccord


Evolent Health reports Q1 adjusted EPS (2c), consensus (5c)

2026-05-07T15:15:00.000Z - 3 months ago

Evolent Health reports Q1 adjusted EPS (2c), consensus (5c)


Evolent Health Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Evolent Health Earnings Call Transcript: Q1 2026


Evolent Health Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Evolent Health Earnings release: Q1 2026


Evolent Health Slides: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Evolent Health Slides: Q1 2026


Evolent Health Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Evolent Health Quarterly report: Q1 2026


Evolent Announces First Quarter 2026 Results

May 7, 2026, 7:00 AM EDT - 3 months ago

Evolent Announces First Quarter 2026 Results


Evolent Health Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Evolent Health Proxy statement: Proxy filing


Evolent Health Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Evolent Health Proxy statement: Proxy filing


Evolent Health appoints Archie Mayani as Chief Product Officer

2026-03-19T12:56:59.000Z - 5 months ago

Evolent Health appoints Archie Mayani as Chief Product Officer


Evolent to Participate in Upcoming Investor Conferences

Feb 26, 2026, 5:00 PM EST - 6 months ago

Evolent to Participate in Upcoming Investor Conferences


Evolent Health price target lowered to $5 from $10 at UBS

2026-02-26T13:16:53.000Z - 6 months ago

Evolent Health price target lowered to $5 from $10 at UBS


Evolent Health price target lowered to $4 from $6 at Citi

2026-02-26T11:37:03.000Z - 6 months ago

Evolent Health price target lowered to $4 from $6 at Citi


Evolent Health Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

Evolent Health Earnings Call Transcript: Q4 2025


Evolent Health Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

Evolent Health Annual report: Q4 2025


Evolent Health Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

Evolent Health Earnings release: Q4 2025


Evolent Health Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

Evolent Health Slides: Q4 2025


Evolent Health Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Evolent Health Earnings Call Transcript: Q3 2025


Evolent Health Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Evolent Health Quarterly report: Q3 2025


Evolent Health Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Evolent Health Earnings release: Q3 2025


Evolent Health Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Evolent Health Slides: Q3 2025


Evolent Announces Third Quarter 2025 Results

Nov 6, 2025, 4:10 PM EST - 10 months ago

Evolent Announces Third Quarter 2025 Results


Evolent Health Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Earnings Call Transcript: Q2 2025


Evolent Health Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Quarterly report: Q2 2025


Evolent Health Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Earnings release: Q2 2025


Evolent Health Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Slides: Q2 2025


Evolent Announces Second Quarter 2025 Results

Aug 7, 2025, 4:10 PM EDT - 1 year ago

Evolent Announces Second Quarter 2025 Results


Evolent announces key appointments to leadership team

Jul 9, 2025, 8:00 AM EDT - 1 year ago

Evolent announces key appointments to leadership team


Evolent Health Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Earnings Call Transcript: Q1 2025


Evolent Health Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Quarterly report: Q1 2025


Evolent Health Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Earnings release: Q1 2025


Evolent Health Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Slides: Q1 2025


Evolent Announces First Quarter 2025 Results

May 8, 2025, 4:10 PM EDT - 1 year ago

Evolent Announces First Quarter 2025 Results


Evolent Health Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Evolent Health Proxy statement: Proxy Filing


Evolent Health Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Evolent Health Proxy statement: Proxy Filing


Evolent Health Earnings Call Transcript: Q4 2024

Feb 20, 2025, 5:00 PM EST - 1 year ago

Evolent Health Earnings Call Transcript: Q4 2024


Evolent Health Annual report: Q4 2024

Feb 20, 2025, 5:00 PM EST - 1 year ago

Evolent Health Annual report: Q4 2024


Evolent Health Earnings release: Q4 2024

Feb 20, 2025, 5:00 PM EST - 1 year ago

Evolent Health Earnings release: Q4 2024


Evolent Health Slides: Q4 2024

Feb 20, 2025, 5:00 PM EST - 1 year ago

Evolent Health Slides: Q4 2024


Evolent Announces Fourth Quarter and Full Year 2024 Results

Feb 20, 2025, 4:10 PM EST - 1 year ago

Evolent Announces Fourth Quarter and Full Year 2024 Results


Evolent Health Announces Changes to Board of Directors

Feb 4, 2025, 7:00 AM EST - 1 year ago

Evolent Health Announces Changes to Board of Directors


Evolent Health Earnings Call Transcript: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Evolent Health Earnings Call Transcript: Q3 2024


Evolent Health Quarterly report: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Evolent Health Quarterly report: Q3 2024


Evolent Health Earnings release: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Evolent Health Earnings release: Q3 2024


Evolent Health Slides: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Evolent Health Slides: Q3 2024


Evolent Announces Third Quarter 2024 Results

Nov 7, 2024, 4:10 PM EST - 1 year ago

Evolent Announces Third Quarter 2024 Results


Evolent Health Inc (EVH) Stock Price Down 3.2% on Oct 2

Oct 2, 2024, 12:08 PM EDT - 2 years ago

Evolent Health Inc (EVH) Stock Price Down 3.2% on Oct 2


Evolent Health Earnings Call Transcript: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Earnings Call Transcript: Q2 2024


Evolent Health Quarterly report: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Quarterly report: Q2 2024


Evolent Health Earnings release: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Earnings release: Q2 2024


Evolent Health Slides: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Slides: Q2 2024


Evolent Announces Second Quarter 2024 Results

Aug 8, 2024, 4:10 PM EDT - 2 years ago

Evolent Announces Second Quarter 2024 Results


Evolent Health Earnings Call Transcript: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Earnings Call Transcript: Q1 2024


Evolent Health Quarterly report: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Quarterly report: Q1 2024


Evolent Health Earnings release: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Earnings release: Q1 2024


Evolent Health Slides: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Slides: Q1 2024


Evolent Announces First Quarter 2024 Results

May 9, 2024, 4:10 PM EDT - 2 years ago

Evolent Announces First Quarter 2024 Results


Evolent Health Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Evolent Health Proxy statement: Proxy Filing


Evolent Health Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Evolent Health Proxy statement: Proxy Filing


Evolent Health Earnings Call Transcript: Q4 2023

Feb 22, 2024, 5:00 PM EST - 2 years ago

Evolent Health Earnings Call Transcript: Q4 2023


Evolent Health Annual report: Q4 2023

Feb 22, 2024, 5:00 PM EST - 2 years ago

Evolent Health Annual report: Q4 2023


Evolent Health Earnings release: Q4 2023

Feb 22, 2024, 5:00 PM EST - 2 years ago

Evolent Health Earnings release: Q4 2023


Evolent Health Slides: Q4 2023

Feb 22, 2024, 5:00 PM EST - 2 years ago

Evolent Health Slides: Q4 2023


Evolent Announces Fourth Quarter and Full Year 2023 Results

Feb 22, 2024, 4:10 PM EST - 2 years ago

Evolent Announces Fourth Quarter and Full Year 2023 Results


Evolent Health Slides: FY 2024

Jan 9, 2024, 6:45 PM EST - 2 years ago

Evolent Health Slides: FY 2024


Evolent Health Earnings Call Transcript: Q3 2023

Nov 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Earnings Call Transcript: Q3 2023


Evolent Health Quarterly report: Q3 2023

Nov 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Quarterly report: Q3 2023


Evolent Health Earnings release: Q3 2023

Nov 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Earnings release: Q3 2023


Evolent Health Slides: Q3 2023

Nov 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Slides: Q3 2023


Evolent Announces Third Quarter 2023 Results

Nov 2, 2023, 4:10 PM EDT - 3 years ago

Evolent Announces Third Quarter 2023 Results


Evolent Health to Participate in Upcoming Conferences

Aug 8, 2023, 5:00 PM EDT - 3 years ago

Evolent Health to Participate in Upcoming Conferences


Evolent Health Earnings Call Transcript: Q2 2023

Aug 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Earnings Call Transcript: Q2 2023


Evolent Health Quarterly report: Q2 2023

Aug 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Quarterly report: Q2 2023


Evolent Health Earnings release: Q2 2023

Aug 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Earnings release: Q2 2023


Evolent Health Slides: Q2 2023

Aug 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Slides: Q2 2023


Evolent Announces Second Quarter 2023 Results

Aug 2, 2023, 4:10 PM EDT - 3 years ago

Evolent Announces Second Quarter 2023 Results


Evolent welcomes Toyin Ajayi to its Board of Directors

Jul 26, 2023, 4:42 PM EDT - 3 years ago

Evolent welcomes Toyin Ajayi to its Board of Directors


BPler
BPler Aug. 18 at 7:47 PM
$EVH https://www.marketbeat.com/instant-alerts/evolent-health-nyseevh-price-target-raised-to-600-2026-08-18/
0 · Reply
PatBtmn
PatBtmn Aug. 18 at 7:28 PM
0 · Reply
BRITLS
BRITLS Aug. 18 at 7:20 PM
$EVH hmm
0 · Reply
StellaLunaSun
StellaLunaSun Aug. 18 at 4:20 PM
$EVH @BPler I just wanted to do something nice for you – maybe it’ll help you, and you’ll be pleased with it – so I’ve picked this out for you. Best wishes https://www.marketbeat.com/instant-alerts/evolent-health-nyseevh-price-target-raised-to-600-2026-08-18/
0 · Reply
BPler
BPler Aug. 18 at 1:54 PM
$EVH Averaging down, at this point there is only upside in my
0 · Reply
PatBtmn
PatBtmn Aug. 17 at 6:24 PM
$EVH fuck it
0 · Reply
TOMKiLA
TOMKiLA Aug. 15 at 12:43 AM
$EVH I can wait here for big changes, I’m very ready to read about good news. $650M new agreements in the first half 2026, this is very good news. I mean, this company is offering different serivices and the big names are coming quickly. I’m very sad about the EBITDA forecasts for next year because is like 4.5% of gross profits (the company was talking about 10%). Something is cooking probably, this company is very interesting
0 · Reply
StellaLunaSun
StellaLunaSun Aug. 14 at 8:11 AM
$EVH https://seekingalpha.com/news/4632078-michael-burry-adds-to-molina-healthcare-position-cites-long-term-outlook-and-political-catalyst
0 · Reply
Zephix
Zephix Aug. 13 at 9:27 PM
0 · Reply
Zephix
Zephix Aug. 13 at 8:44 PM
$EVH Today0
0 · Reply
WM24
WM24 Aug. 13 at 7:35 PM
$EVH about time. Let’s keep it up.
1 · Reply
BRITLS
BRITLS Aug. 13 at 7:24 PM
$EVH must be a macro thing
0 · Reply
PatBtmn
PatBtmn Aug. 13 at 4:43 PM
$EVH go bitch go
0 · Reply
StellaLunaSun
StellaLunaSun Aug. 13 at 1:57 PM
$EVH https://seekingalpha.com/article/4936013-evolent-health-q2-earnings-review-debt-is-distressing-but-business-is-booming
0 · Reply
BRITLS
BRITLS Aug. 12 at 3:24 PM
$EVH I'm thankful for the macro market for this 5% gain /s
1 · Reply
BRITLS
BRITLS Aug. 11 at 11:39 PM
$EVH lol Stella the big baby of the board
0 · Reply
StellaLunaSun
StellaLunaSun Aug. 11 at 7:10 PM
$EVH Once again, the share price has closed lower – it’s sickening. As I said, this share’s price is always tied to the wider economic climate; even if there’s just a hint of concern that interest rates might rise, the price plummets. This share is currently only being used for day trading. Everyone’s in today and will be out again quickly before the close, ahead of tomorrow’s CPI data. Scenario A (Miss): The core rate (Core MoM) comes in at 0.0% or +0.1%. Consequence: the Fed has no reason to raise interest rates and will pause in September. Scenario B: exactly at +0.1% or +0.2%. Consequence: Combined with the weak labour market, this is likely to be enough for the doves at the Fed to pause on interest rates. Scenario C: The figure is +0.3% or higher. Consequence: Inflation is rising unexpectedly sharply. The Fed will most likely raise interest rates in September. In Scenario 1, the share price will rise sharply tomorrow and I think it will finally close in positive territory.
0 · Reply
StellaLunaSun
StellaLunaSun Aug. 11 at 4:50 PM
$EVH hoping at least this orange resist line will hold but i think not
0 · Reply
StellaLunaSun
StellaLunaSun Aug. 11 at 4:47 PM
$EVH We’re already 6 cents below yesterday’s high again. The share price keeps going up and then down again. We’re not really making any headway. We haven’t closed above $4.20 for the past three days; it just keeps rising and falling, and either opens every day with a massive downward gap or closes every day with a massive downward gap. But to be fair, many shares are following this pattern TODAY – everyone’s nervous about tomorrow’s CPI data.
0 · Reply
StellaLunaSun
StellaLunaSun Aug. 11 at 4:44 PM
$EVH Yes, actually, I agree – that was definitely outright market manipulation. First they drove the share price down to make money, and now they’re pushing it back up by buying it up. They can be reported to the SEC for this, and the excuse that ‘at $6 the share was a risk, but at $4.20 it isn’t’ doesn’t hold water either. Lots of banks use that excuse with the SEC, but it’s daft that they say, ‘At $4.20, the share offers a 46 per cent upside, so buy’, well, it’s a bit of a problem that that 50 per cent would actually be more than $6 – so you can’t use that argument either, because then they’re valuing the share at even more than $6, at which point they supposedly thought the share was too risky, which is why it was on the warning list. It was quite obviously a case of serious market manipulation. It really gets on my nerves...
0 · Reply
BPler
BPler Aug. 11 at 3:42 PM
$EVH Citi group single handly helped to cut this stock nearly -50% within a month and now they change the rating to buy. Market makers at their best.
0 · Reply
StellaLunaSun
StellaLunaSun Aug. 11 at 3:22 PM
0 · Reply